Efficacy and safety of mirabegron, a β3 -adrenoceptor agonist, in patients with detrusor hyperactivity and impaired contractility.
Cheng-Ling LeeHann-Chorng KuoPublished in: Lower urinary tract symptoms (2018)
Mirabegron was an effective treatment option in elderly patients with urodynamic DO and DHIC in the present study. The AEs reported were mild and infrequent.